Journal
/
Medicine
/
Desarrollo de un modelo basado en la rata alfa-sinucleína para la enfermedad de Parkinson mediante inyección estereotáctica de un vector viral adeno-asociado recombinante…
JoVE Journal
Medicine
Medicine
A subscription to JoVE is required to view this content.
Desarrollo de un modelo basado en la rata alfa-sinucleína para la enfermedad de Parkinson mediante inyección estereotáctica de un vector viral adeno-asociado recombinante
The JoVE video player is compatible with HTML5 and Adobe Flash. Older browsers that do not support HTML5 and the H.264 video codec will still use a Flash-based video player. We recommend downloading the newest version of Flash here, but we support all versions 10 and above.
If that doesn't help, please let us know.
Unable to load video. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
An unexpected error occurred. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
Click here for the English version
Article
DOI:
10.3791/53670-v
•
08:33 min
•
February 28th, 2016
Desarrollo de un modelo basado en la rata alfa-sinucleína para la enfermedad de Parkinson mediante inyección estereotáctica de un vector viral adeno-asociado recombinante
February 28th, 2016
•
Anke Van der Perren1, Cindy Casteels2, Koen Van Laere2, Rik Gijsbers3,4, Chris Van den Haute1,4, Veerle Baekelandt1
1Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, 2Division of Nuclear Medicine, Leuven University Hospital - KU Leuven, 3Laboratory for Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 4Leuven Viral Vector Core, KU Leuven